News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘Leukemia’ clear

  • Dana-Farber scientists report in the Journal of Clinical Investigation they have developed a tumor vaccine based on the patient’s tumor to create a strong and selective immune response in some chronic lymphocytic leukemia patients.

Tags: ImmuneSystem, Leukemia

  • The Leukemia & Lymphoma Society and Dana-Farber joined together to establish the Blood Cancer Research Partnership, an innovative program bringing together a network of sites for clinical trial testing of blood cancer therapies in community oncology settings across the country.

Tags: Leukemia, Lymphoma

  • Dana-Farber scientists have safely shut down breast cancer and a form of leukemia in mice by targeting abnormal proteins to which the cancers are "addicted."

Tags: BasicResearch, BreastCancer, Leukemia

  • Dana-Farber and Broad Institute researchers for the first time are able to show the past, present, and future of CLL tumors.

Tags: Genetics, Leukemia

  • Dana-Farber Cancer Institute scientists provide the first statistically-based guidelines for determining whether stem cell transplant is appropriate for patients older than 60 with myelodysplastic syndromes (MDS)

Tags: StemCellTransplant, Leukemia

  • An analysis of two dozen clinical studies finds most adults with poor-risk and intermediate-risk acute myeloid leukemia benefit from allogeneic stem cell transplants.

Tags: BasicResearch, StemCellTransplant, Leukemia

  • Researchers report that patients with high-risk acute AML who received a cancer vaccine after a stem cell transplant had few complications and mounted a strong immune system attack on the disease.

Tags: StemCellTransplant, Leukemia

  • The pre-cancerous blood disorder myelodsysplastic syndrome (MDS) affects between 35,000 and 55,000 people in the United States. Dana-Farber's David Steensma, MD, discusses MDS and its treatment.

Tags: StemCellTransplant, Leukemia

  • Stand Up To Cancer announced the second round of awards for its Innovative Research Grants Program, naming the 13 young scientists who will receive a combined $9.74 million to conduct high-risk/high-reward translational cancer research. Dana-Farber's Catherine J. Wu, MD, is one of the recipients.

Tags: Grants, Honors, Prevention, Leukemia

  • Scientists have found a way to switch off the behavior of a protein that drives uncontrolled cell growth in tumors.

Tags: Leukemia

Showing 1-10 of 29 items